Exchange: NASDAQ
-1.42% $25.85
America/New_York / 25 apr 2024 @ 16:00
FUNDAMENTALS | |
---|---|
MarketCap: | 20.69 mill |
EPS: | 1.677 |
P/E: | 15.41 |
Earnings Date: | N/A |
SharesOutstanding: | 0.800 mill |
Avg Daily Volume: | 0.0055 mill |
PE RATIO: COMPANY / SECTOR |
---|
1.05x |
Company: PE 15.41 | sector: PE 14.70 |
PE RATIO: COMPANY / INDUSTRY |
---|
0.89x |
Company: PE 15.41 | industry: PE 17.27 |
DISCOUNTED CASH FLOW VALUE |
---|
N/A |
N/A |
Expected Trading Range (DAY) |
---|
$ 25.63 - 26.07 ( +/- 0.85%) |
ATR Model: 14 days |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 |
Volume Signals | |
---|---|
Price | $25.85 (-1.42% ) |
Volume | 0.0006 mill |
Avg. Vol. | 0.0055 mill |
% of Avg. Vol | 10.41 % |
Signal 1: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depository receipts that comprise the index. The index is designed to provide exposure to U.S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and weighted based upon their cumulative score on three investing factors: volatility, value and growth. It is non-diversified.